Chromatin accessibility changes at intergenic regions are associated with ovarian cancer drug resistance.

John GallonErick LoomisEdward CurryNicholas MartinLeigh BrodyIan GarnerRobert BrownJames M Flanagan

Published in: Clinical epigenetics (2021)

Chromatin changes at intergenic regulators of gene expression are associated with in vivo derived drug resistance and Pt-adduct distribution in patient-derived HGSOC drug resistance models.

Keyphrases

gene expression
transcription factor
dna damage
dna methylation
genome wide